Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review

OBJECTIVES: To examine the evidence derived from randomized controlled clinical trials on the efficacy and safety of omalizumab compared to placebo in controlling symptoms of chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU). DATA SOURCE: The electronic databases PubMed, Medline,...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrillo, Diana C, Borges, Mario Sanchez, García, Elizabeth, Egea, Eduardo, Serrano, Carlos D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280746/
https://www.ncbi.nlm.nih.gov/pubmed/25566332
http://dx.doi.org/10.1186/s40413-014-0050-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280746/
https://www.ncbi.nlm.nih.gov/pubmed/25566332
http://dx.doi.org/10.1186/s40413-014-0050-z

Ejemplares similares